X-8170052-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_016378.3(VCX2):c.400G>A(p.Val134Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,195,230 control chromosomes in the GnomAD database, including 2 homozygotes. There are 138 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_016378.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.400G>A | p.Val134Ile | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 | |
LOC107985675 | XR_001755783.2 | n.1915-58283C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.400G>A | p.Val134Ile | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309 | P1 | |
ENST00000659022.1 | n.972-58283C>T | intron_variant, non_coding_transcript_variant | ||||||||
ENST00000649338.1 | n.263-58283C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 35AN: 98724Hom.: 1 Cov.: 15 AF XY: 0.000449 AC XY: 10AN XY: 22278
GnomAD3 exomes AF: 0.000688 AC: 125AN: 181740Hom.: 0 AF XY: 0.000724 AC XY: 49AN XY: 67640
GnomAD4 exome AF: 0.000347 AC: 381AN: 1096506Hom.: 1 Cov.: 76 AF XY: 0.000353 AC XY: 128AN XY: 362854
GnomAD4 genome AF: 0.000355 AC: 35AN: 98724Hom.: 1 Cov.: 15 AF XY: 0.000449 AC XY: 10AN XY: 22278
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at